Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA

Author(s)

• Breggin, Peter Roger

Bibliographic Information

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA

Peter R. Breggin

Springer Pub. Co., c1997

Note

***遡及データをもとにした流用入力である

Includes bibliographical references (p. 234-293) and index

Details

• NCID: BA41535250
• ISBN:
  • 0826194907
• LCCN: 97003969
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: New York
• Pages/Volumes: xii, 306 p.
• Size: 24 cm
• Classification:
  • LCC : RC483
  • NLM : WM 400 B833b 1997
  • DC21 : 616.89/1
• Subject Headings:
  • LCSH : Psychotropic drugs -- Side effects
  • LCSH : Brain -- Effect of drugs on
  • LCSH : Electroconvulsive therapy -- Complications
  • LCSH : Iatrogenic diseases
  • LCSH : Brain damage -- Etiology
  • MESH : Mental Disorders -- therapy
  • MESH : Brain Damage, Chronic -- etiology
  • MESH : Psychotropic Drugs -- adverse effects
  • MESH : Electroconvulsive Therapy -- adverse effects
  • MESH : Drug Industry -- United States -- legislation